Mestastop Solutions
Mestastop Solutions develops proprietary platforms to unravel metastasis biology for drug discovery and companion diagnostics in oncology.
Private Company
Funding information not available
AI Company Overview
Mestastop Solutions develops proprietary platforms to unravel metastasis biology for drug discovery and companion diagnostics in oncology.
Technology Platform
Three proprietary platforms (METAssay®, METVivo®, METSCAN®) that integrate wet lab biology with machine learning to dissect metastasis into 30 functional steps for drug discovery and companion diagnostics.
Opportunities
Risk Factors
Competitive Landscape
Few companies specialize specifically in metastasis biology; Mestastop differentiates through its integrated platform approach combining functional assays, animal models, and patient-derived data with machine learning analytics.